Journal Article DZNE-2025-00139

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Alzheimer-Demenz und Antidementiva-Verordnungen 2010–2021 in 357 Hausarzt- und 71 Facharztpraxen | Alzheimer's Dementia and Anti-Dementia Medication Prescriptions 2010-2021 in 357 GP Practices and 71 Specialist Practices

 ;  ;

2025
Thieme Stuttgart

Psychiatrische Praxis 52(1), 44 - 47 () [10.1055/a-2370-1933]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: The predicted prevalence of people with dementia (PWD) in Germany has risen to 1.8 million since 2010. In the near future, we will see the approval of antibody therapies. The study aims to demonstrate the recent anti-dementia medication prescriptions and diagnosis prevalence.Data from 357 general practitioner (GP) and 71 specialist practices (SP) (1.1 Mio. patients) were analyzed to demonstrate the prevalence of dementia diagnoses and anti-dementia drug prescriptions between 2010 and 2021.The diagnosis prevalence of PWD (Alzheimer's dementia) remained relatively constant in GP practices at 1.0-1.3% (0.19-0.21%). Among SP, the prevalence increased from 4.9% (2.8%) to 5.9% (3.6%). The anti-dementia prescription rate decreased in GP (from 0.14% to 0.10%) and increased in SP practices (from 2.1% to 2.4%).The diagnosis and prescription rate, especially in GP practices, remained below the prevalence forecasts and the expected prescriptions.

Keyword(s): Alzheimer Disease: drug therapy (MeSH) ; Alzheimer Disease: epidemiology (MeSH) ; Alzheimer Disease: diagnosis (MeSH) ; Humans (MeSH) ; Germany (MeSH) ; Aged (MeSH) ; General Practice: statistics & numerical data (MeSH) ; Male (MeSH) ; Female (MeSH) ; Aged, 80 and over (MeSH) ; Practice Patterns, Physicians': statistics & numerical data (MeSH) ; Forecasting (MeSH) ; Drug Prescriptions: statistics & numerical data (MeSH) ; Cross-Sectional Studies (MeSH) ; Dementia: drug therapy (MeSH) ; Dementia: epidemiology (MeSH) ; Nootropic Agents: therapeutic use (MeSH) ; Nootropic Agents

Classification:

Contributing Institute(s):
  1. Patient-Reported Outcomes and Health Economics Research (AG Michalowsky)
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Appears in the scientific report 2025
Database coverage:
Medline ; Clarivate Analytics Master Journal List ; Current Contents - Social and Behavioral Sciences ; Essential Science Indicators ; IF < 5 ; JCR ; SCOPUS ; Social Sciences Citation Index
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > ROS DZNE > ROS DZNE-AG Michalowsky
Document types > Articles > Journal Article
Public records
Publications Database

 Record created 2025-01-14, last modified 2025-01-26



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)